| Fonds | 2026/Q1 | 2025/Q4 | 2025/Q3 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | |
| 154.492.572 $ | -295.010.846 $ | -65,9 % | 1.011.283.559 $ | +350.894.444 $ | +150,1 % | 547.895.728 $ | +230.748.251 $ | +74,3 % | |
| FMR LLC | 72.914.070 $ | -131.205.123 $ | -64,3 % | 204.119.193 $ | +52.013.759 $ | +34,2 % | 152.105.434 $ | +64.958.488 $ | +74,5 % |
| ORBIMED ADVISORS LLC | 51.242.301 $ | -103.338.640 $ | -66,9 % | 154.580.941 $ | +47.484.532 $ | +44,3 % | 107.096.409 $ | +44.580.802 $ | +71,3 % |
| BlackRock, Inc. | 30.336.201 $ | -60.467.083 $ | -66,6 % | 90.803.284 $ | +41.827.575 $ | +85,4 % | 48.975.709 $ | +25.956.073 $ | +112,8 % |
| Decheng Capital LLC | 85.334.568 $ | +23.538.207 $ | +38,1 % | 61.796.361 $ | +25.723.844 $ | +71,3 % | |||
| NORGES BANK | 78.263.866 $ | +67.614.188 $ | +634,9 % | ||||||
| Enavate Sciences GP, LLC | 66.780.936 $ | +20.513.923 $ | +44,3 % | 46.267.013 $ | +19.259.474 $ | +71,3 % | |||
| VANGUARD GROUP INC | 64.846.119 $ | +18.901.734 $ | +41,1 % | 45.944.385 $ | +22.108.638 $ | +92,8 % | |||
| UBS Group AG | 49.039.498 $ | +43.918.080 $ | +857,5 % | ||||||
| Bain Capital Life Sciences Investors, LLC | 36.097.120 $ | -9.790.590 $ | -21,3 % | 45.887.710 $ | +19.101.583 $ | +71,3 % | |||
| Janus Henderson Group Ltd. | 41.422.941 $ | ||||||||
| TCG Crossover Management, LLC | 39.822.707 $ | +9.059.349 $ | +29,4 % | ||||||
| Altshuler Shaham Ltd | 36.422.811 $ | +9.772.389 $ | +36,7 % | ||||||
| Omega Fund Management, LLC | 36.008.855 $ | +10.496.984 $ | +41,1 % | ||||||
| STATE STREET CORP | 35.816.986 $ | +14.851.717 $ | +70,8 % | ||||||
| Venrock Adviser, LLC | 31.746.441 $ | +9.751.946 $ | +44,3 % | ||||||
| 154.492.572 $ | -295.010.846 $ | -65,9 % | 1.011.283.559 $ | +350.894.444 $ | +150,1 % | 547.895.728 $ | +230.748.251 $ | +74,3 % | |